You are viewing: France Structural Heart Devices Market analysis

The France Structural Heart Devices Market was valued at $359.7 Million in 2024 and projected to reach to $559.8 Million by 2029, representing a compound annual growth rate of 9.2%. France's structural heart devices market is positioned for sustained growth through 2029, driven by demographic pressures and healthcare modernization.

France Structural Heart Devices Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

France Structural Heart Devices Market Trends and Insights

  • This expansion reflects France's aging population, rising prevalence of valvular and congenital heart diseases, and increasing adoption of minimally invasive interventional procedures.
  • France benefits from strong healthcare infrastructure, favorable reimbursement policies, and a well-established network of cardiac centers that drive demand for advanced structural heart solutions. The French market is characterized by growing investment in transcatheter technologies and a shift toward catheter-based interventions over traditional surgical approaches.
  • France's participation in European clinical trials and regulatory harmonization under CE marking standards accelerates device adoption and innovation.
  • Between 2024 and 2029, France is expected to see heightened competition among device manufacturers and increased focus on patient outcomes, cost-effectiveness, and procedural efficiency in structural heart care..

Key Market Statistics

  • CAGR (2024-2029) 9.2% CAGR
  • Market Size, 2024 ~USD 359.7 Million
  • Forecast, 2029 ~USD 559.8 Million
  • Country France

France Structural Heart Devices Market Overview

Market Valuation Growth :

France's structural heart devices market is valued at USD 359.7 million in 2024, with a projected CAGR of 9.2% through 2029, reaching USD 559.8 million by forecast end.

Aging Population Driver :

France's demographic shift toward an older population is significantly increasing the prevalence of valvular and congenital heart diseases, driving demand for structural heart interventions.

Minimally Invasive Adoption :

French healthcare providers are increasingly adopting minimally invasive interventional procedures, reducing patient recovery times and hospital stays while improving clinical outcomes.

Healthcare Infrastructure Strength :

France's robust healthcare system, advanced medical facilities, and strong reimbursement policies support rapid adoption and integration of innovative structural heart device technologies.

France Structural Heart Devices Market Dynamics

  • The country's aging population, combined with rising incidence of valvular diseases, creates consistent demand for innovative treatment solutions.
  • French healthcare providers' commitment to minimally invasive techniques aligns with global trends, enhancing patient outcomes and procedural efficiency.
  • Reimbursement support from the French healthcare system ensures accessibility to advanced devices, while strong hospital infrastructure facilitates rapid technology adoption and clinical implementation across major medical centers..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • France's structural heart devices market is valued at USD 359.7 million in 2024 and will grow to USD 559.8 million by 2029, representing a 9.2% CAGR.
    • France's aging demographic and rising cardiovascular disease burden are primary drivers of structural heart device adoption across the country.
    • Minimally invasive transcatheter procedures are increasingly preferred in France, shifting the market away from traditional open-heart surgery.
    • France's robust healthcare system and CE marking regulatory pathway support rapid innovation and market entry for structural heart device manufacturers.

    Structural Heart Devices Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment TAVR/TAVI PROCEDURES (Type)
    Forecast Period 2024-2029
    Growth Rate CAGR of 9.5% from 2024 to 2029
    Largest Segment HOSPITALS (End User)
    Market Size Base Year (Billions) ~USD 16.32 (2024)
    Revenue Forecast (Billions) ~USD 25.69 (2029)
    Segments Covered Procedure, Type, Product, End User, Accessories

    France Structural Heart Devices Market Report Segmentation

    5 segment dimensions are covered across the global market.

    By Procedure

    • Repair Procedures
    • Replacement Procedures

    By Type

    • Annuloplasty
    • Biological Valves
    • Catheters
    • Closure Procedures
    • Guidewires
    • Mechanical Valves
    • Other Accessories
    • Savr Procedures
    • Sheaths
    • Surgical Heart Valves
    • Surgical Valves
    • Tavr/Tavi Procedures
    • Teer Procedures
    • Tmvr Procedures
    • Transcatheter Aortic Valve Replacement (Tavr)
    • Transcatheter Heart Valves
    • Transcatheter Mitral Valve Replacement (Tmvr)
    • Valvuloplasty

    By Product

    • Accessories
    • Annuloplasty Rings
    • Heart Valve Devices
    • Occluders, Closure Systems And Delivery Systems
    • Occluders, Closure Systems, And Delivery Systems

    By End User

    • Ambulatory Surgical Centers
    • Ambulatory Surgical Centres
    • Hospitals
    • Other Accessories
    • Other End Users
    • Other End Users (Cath Labs, Cardiac Centers )
    • Other End Users (Cath Labs, Cardiac Centers)
    • Other End Users (Cath Labs, Cardiac Centres)
    • Others End Users

    By Accessories

    • Catheters
    • Guidewires
    • Other Accessories
    • Sheaths

    FRANCE: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    AMBULATORY SURGICAL CENTERS67.873.278.784.791.198.2105.9114.47.8
    HOSPITALS456.8496536.9581.6630.2683.7742.4806.78.5
    OTHER END USERS (CATH LABS, CARDIAC CENTERS)62.368.374.681.589.197.6106.9117.29.5
    TOTAL586.9637.5690.1747.8810.5879.5955.21038.38.5

    Target Audience

    • Medical Device Manufacturers : Device companies need France-specific market data to develop localized go-to-market strategies, understand competitive positioning, and identify growth opportunities in this EUR 5+ billion healthcare market.
    • Healthcare Investors & PE Firms : Investment professionals require detailed French market forecasts and growth drivers to evaluate acquisition targets, assess portfolio company performance, and identify high-potential healthcare investments.
    • Hospital & Cardiology Centers : French healthcare institutions need market intelligence on device innovations, reimbursement trends, and clinical adoption patterns to optimize procurement decisions and budget allocation.
    • Regulatory & Market Access Teams : Regulatory professionals and market access specialists require France-specific insights on healthcare policies, reimbursement mechanisms, and competitive dynamics for successful product launches.
    • Strategic Consultants & Analysts : Consulting firms and research analysts need comprehensive France market data to support client advisory work, competitive benchmarking, and strategic planning in the structural heart device sector.

    Reasons to Buy this Report

    • Market-Specific Sizing & Forecasts : Access precise valuation data for France's structural heart devices market with country-specific CAGR of 9.2%, enabling accurate financial planning and investment decisions tailored to French market dynamics.
    • Demographic & Clinical Insights : Understand France's aging population trends and rising prevalence of valvular and congenital heart diseases, identifying key patient segments and clinical opportunities unique to the French healthcare landscape.
    • Reimbursement & Healthcare Policy Analysis : Gain detailed insights into France's healthcare reimbursement framework and regulatory environment, essential for pricing strategies and market entry planning in this regulated European market.
    • Competitive Landscape for France : Identify leading device manufacturers, market share distribution, and competitive positioning specific to France, enabling strategic partnerships and differentiation in this high-value market.
    • Minimally Invasive Procedure Trends : Analyze France's adoption rates of minimally invasive interventional procedures and technology preferences among French cardiologists, informing product development and marketing strategies.

    Frequently asked questions

    What is the current size of France's structural heart devices market?

    France's structural heart devices market was valued at USD 359.7 million in 2024 and is expected to reach USD 559.8 million by 2029.

    What is the projected growth rate for structural heart devices in France?

    France's structural heart devices market is projected to grow at a compound annual growth rate (CAGR) of 9.2% from 2024 to 2029.

    What factors are driving growth in France's structural heart devices market?

    Key growth drivers in France include an aging population, increasing prevalence of valvular heart disease, rising adoption of minimally invasive procedures, strong healthcare infrastructure, and favorable reimbursement policies.

    Which structural heart device types are most popular in France?

    Transcatheter aortic valve replacement (TAVR), mitral valve repair devices, and left atrial appendage (LAA) closure devices are among the most widely adopted structural heart solutions in France.

    How does France's regulatory environment affect structural heart device adoption?

    France's alignment with European CE marking standards and participation in clinical trials accelerates device approval and adoption, creating a favorable environment for manufacturers and healthcare providers.

    RESEARCH METHODOLOGY

    The study involved four major activities to estimate the current size of the Structural heart devices market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to to identify and collect information for the study of Structural heart devices market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    Extensive primary research was conducted after obtaining information regarding the Structural heart devices market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, product development/innovation teams, and related key executives from manufacturers; distributors operating in the Structural heart devices market.; and key opinion leaders.

    Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to technology, application, vertical, and region. Stakeholders from the demand side customers/end users who are using infection control products were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage and the future outlook of their business, which will affect the overall market.

    The following is a breakdown of the primary respondents:

    Structural Heart Devices Market

    Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.

    Note 2: Other primaries include sales managers, marketing managers, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue.

    As of 2023: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=< USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The research methodology used to estimate the size of the Structural heart devices market includes the following details.

    The market sizing of the market was undertaken from the global side.

    Country-level Analysis: The size of the Structural heart devices market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall Structural heart devices market was obtained from secondary data and validated by primary participants to arrive at the total Structural heart devices market. Primary participants further validated the numbers.

    Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:

    Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

    Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

    At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall Structural heart devices market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

    Global Structural heart dsevices market size : Top-Down and Bottom-Up Approach

    Structural Heart Devices Market

    Data Triangulation

    The market was split into several segments and subsegments after arriving at the overall market size—using the market size estimation processes. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Structural heart devices market.

    Market Definition

    Structural Heart devices are used to treat conditions such as aortic valve disease, mitral valve disease, atrial septal defect, ventricular septal defect, hypertrophic cardiomyopathy, and tricuspid and pulmonic valve disease. Structural heart devices can be used to close holes in the heart, open narrowed heart valves, or replace damaged valves.

    Stakeholders

    • Medical Device Manufacturers
    • Cardiologists
    • Interventional Cardiologist
    • Healthcare institutions (hospitals and outpatient clinics)
    • Distributors and suppliers
    • Research institutes
    • Health insurance payers
    • Market research and consulting firms

    Report Objectives

    • To define, describe, segment, and forecast the global Structural heart devices market by product, procedure, end user, and region.
    • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets1 concerning individual growth trends, prospects, and contributions to the overall Structural heart devices market.
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
    • To forecast the size of the Structural heart devices market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile key players in the global Structural heart devices market and comprehensively analyze their core competencies2 and market shares.
    • To track and analyze competitive developments such as acquisitions, expansions, partnerships, agreements, and collaborations; and product launches and approvals.
    • To benchmark players within the Structural heart devices market using the "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy.

    Get the Full Structural Heart Devices Market Report

    Full forecast, segment splits, and company analysis for all Structural Heart Devices Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status